Use access key #2 to skip to page content.
$20.78 0.19 (0.92%)
7/3/2008 1:01 PM

Bristol-Myers Squibb Co. (BMY)

CAPS Rating:
****

The Company, through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other health care related products.

View All Commentary (BMY)

Recs

0

Avatar KipLargo (80.43) Submitted: 5/05/08 6:39 PM : Outperform Start Price: $23.60 BMY Score: -2.11

Considering current price, management, drugs, and potential, this is the best company to make money in for big pharma.

Report this Post Replies: 0 | Reply

Featured Broker Partners